Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19

Yong Gao,Tuantuan Li,Mingfeng Han,Xiuyong Li,Dong Wu,Yuanhong Xu,Yulin Zhu,Yan Liu,Xiaowu Wang,Linding Wang
DOI: https://doi.org/10.1002/jmv.25770
IF: 20.693
2020-04-10
Journal of Medical Virology
Abstract:<p>The role of clinical laboratory data in the differential diagnosis of the severe forms of COVID‐19 has not been definitely established. The aim of this study was to look for the warning index in severe COVID‐19 patients. We investigated forty‐three adult patients with COVID‐19. The patients were classified into mild group (28 patients) and severe group (15 patients). Comparison of the haematological parameters between the mild and severe groups showed significant differences in IL‐6, D‐Dimer, GLU, TT, FIB and CRP (<i>P</i> &lt;0.05). The optimal threshold and area under the ROC curve of IL‐6 were 24.3 pg/mL and 0.795 respectively, while those of D‐Dimer were 0.28 µg/L and 0.750, respectively. The area under the ROC curve (AUC) of IL‐6 combined with D‐Dimer was 0.840. The specificity of predicting the severity of COVID‐19 during IL‐6 and D‐Dimer tandem testing was up to 93.3%, while the sensitivity of IL‐6 and D‐Dimer by parallel test in the severe COVID‐19 was 96.4%. IL‐6 and D‐Dimer were closely related to the occurrence of severe COVID‐19 in the adult patients, and their combined detection had the highest specificity and sensitivity for early prediction of the severity of COVID‐19 patients, which has important clinical value.</p><p>This article is protected by copyright. All rights reserved.</p>
virology
What problem does this paper attempt to address?